A year has 8,760 hours. Support the campaign
Vitruvian Shield
Chronic disease

Chronic disease management research

Longitudinal remote monitoring with adaptive visit schedules, PRO-driven interventions, and real-world evidence generation.

Rethinking chronic disease trials

Chronic disease trials span months to years, requiring sustained patient engagement and continuous data collection that traditional visit-based models can't deliver. Vitruvian Shield supports chronic disease research with continuous remote monitoring and adaptive trial designs.

From cardiovascular and metabolic disorders to respiratory and autoimmune conditions, our platform captures the full patient journey, not just snapshots taken during clinic visits, enabling richer safety data, more sensitive efficacy endpoints, and genuine real-world evidence.

Chronic disease capabilities

Longitudinal remote monitoring

Continuous vital signs tracking over months and years, blood pressure trends, glucose variability, respiratory function, weight changes, with automated adherence monitoring and gap detection. Continuous glucose monitoring (Dexcom): designed for, API authorisations in progress.

Adaptive visit schedules

Dynamic visit scheduling that adjusts based on patient health status and study milestones. Reduce unnecessary visits while ensuring critical assessments aren't missed.

PRO-driven interventions

Patient-reported outcome data triggers clinical workflows automatically. Worsening symptom scores initiate investigator alerts, protocol-specified interventions, and safety reporting.

Real-world evidence generation

Structured, continuous data collection generates real-world evidence designed to regulatory data-integrity principles. Supports pragmatic trial designs, registries and post-market surveillance studies.

Medication adherence tracking

Dosing reminders and patient-reported medication logs, with connected adherence devices integrated per study on request. Correlate adherence patterns with clinical outcomes and treatment response.

Cardiovascular and metabolic studies

Configurable workflows for hypertension, diabetes, heart failure and NASH studies, with protocol-defined endpoints, device-specific reference ranges and indication-specific PRO instruments.

Talk to us about your next study

Tell us about the protocol, the countries and the devices. We will show you how the platform would run it.